SARS-CoV-2-specific CD4+ T cells adopted an activated phenotype following vaccination and boosting in PAD patients, with this response characterized by increased cell surface expression of PD1, ICOS, and CD38 (Figures 7C–E; Figures S7B, C). This evidence concerns the gene CD38 and peripheral arterial disease.